EW logo

EW

Edwards Lifesciences CorporationNYSEHealthcare
$81.05-0.26%OpenMarket Cap: $47.07B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

43.99

PEG

P/B

4.55

P/S

7.76

EV/EBITDA

32.23

DCF Value

$61.65

FCF Yield

2.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

78.1%

Operating Margin

26.7%

Net Margin

17.6%

ROE

10.4%

ROA

9.9%

ROIC

11.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$1.57B$91.2M$0.16
FY 2025$6.07B$1.07B$1.83
Q3 2025$1.55B$291.1M$0.50
Q2 2025$1.53B$329.8M$0.56

Analyst Ratings

View All
Piper SandlerOverweight
2026-02-11
Goldman SachsBuy
2026-02-11
BTIGBuy
2026-02-11
Wells FargoOverweight
2026-02-11
Truist SecuritiesHold
2026-02-11

Trading Activity

Insider Trades

View All
BOBO DONALD E JRofficer: CVP,Strategy/Corp Development
SellThu Apr 02
BOBO DONALD E JRofficer: CVP,Strategy/Corp Development
SellThu Apr 02
BOBO DONALD E JRofficer: CVP,Strategy/Corp Development
SellThu Apr 02
Lippis Daniel J.officer: CVP, TAVR
SellWed Mar 11
Lippis Daniel J.officer: CVP, TAVR
SellWed Mar 11

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NYSE

Beta

0.94

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Peers